Shanghai Aohua Photoelectricity Endoscope Co., Ltd. (SHA:688212)
China · Delayed Price · Currency is CNY 38.98
-1.03 (-2.57%)
At close: Mar 9, 2026
SHA:688212 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 773.54 | 747.55 | 677.12 | 445.26 | 347.05 |
Other Revenue | - | 2 | 0.96 | - | - |
| 773.54 | 749.55 | 678.08 | 445.26 | 347.05 | |
Revenue Growth (YoY) | 3.20% | 10.54% | 52.29% | 28.30% | 31.82% |
Cost of Revenue | - | 268.49 | 226.29 | 164.27 | 123.19 |
Gross Profit | 773.54 | 481.06 | 451.79 | 280.99 | 223.86 |
Selling, General & Admin | - | 337.3 | 281.18 | 193.14 | 130.83 |
Research & Development | - | 163.6 | 147 | 96.54 | 49.35 |
Other Operating Expenses | 772.38 | -23.15 | -29.65 | -1.4 | -9.27 |
Operating Expenses | 772.38 | 491.08 | 406.28 | 292.72 | 174.08 |
Operating Income | 1.16 | -10.02 | 45.51 | -11.73 | 49.78 |
Interest Expense | - | -1.94 | -0.7 | -0.63 | -0.31 |
Interest & Investment Income | - | 8.81 | 6.61 | 12.39 | 1.95 |
Currency Exchange Gain (Loss) | - | -0.22 | 0.56 | 0.74 | -2.41 |
Other Non Operating Income (Expenses) | -1.05 | -0.73 | -0.3 | -0.47 | -0.27 |
EBT Excluding Unusual Items | 0.11 | -4.1 | 51.69 | 0.31 | 48.75 |
Impairment of Goodwill | - | -15.83 | -11.55 | - | - |
Gain (Loss) on Sale of Investments | - | 3.89 | 7.91 | 7.75 | 0.03 |
Gain (Loss) on Sale of Assets | - | 0.26 | -0.75 | 0.14 | 0.34 |
Asset Writedown | - | -0.14 | -0.17 | -0.01 | - |
Other Unusual Items | - | 22.35 | 6.78 | 8.8 | 8.59 |
Pretax Income | 0.11 | 6.43 | 53.91 | 16.98 | 57.71 |
Income Tax Expense | -11.36 | -13.9 | -6.86 | -8.07 | -2.06 |
Earnings From Continuing Operations | 11.46 | 20.32 | 60.77 | 25.05 | 59.77 |
Minority Interest in Earnings | - | 0.69 | -2.92 | -3.39 | -2.74 |
Net Income | 11.46 | 21.01 | 57.85 | 21.66 | 57.04 |
Net Income to Common | 11.46 | 21.01 | 57.85 | 21.66 | 57.04 |
Net Income Growth | -45.45% | -63.68% | 167.04% | -62.02% | 208.16% |
Shares Outstanding (Basic) | 127 | 131 | 135 | 135 | 104 |
Shares Outstanding (Diluted) | 127 | 131 | 135 | 135 | 104 |
Shares Change (YoY) | -3.02% | -2.39% | -0.64% | 30.57% | 6.46% |
EPS (Basic) | 0.09 | 0.16 | 0.43 | 0.16 | 0.55 |
EPS (Diluted) | 0.09 | 0.16 | 0.43 | 0.16 | 0.55 |
EPS Growth | -43.75% | -62.79% | 168.75% | -70.91% | 189.47% |
Free Cash Flow | - | -265.55 | -120.42 | -120.67 | -25.45 |
Free Cash Flow Per Share | - | -2.02 | -0.90 | -0.89 | -0.24 |
Dividend Per Share | - | 0.080 | 0.300 | - | 0.190 |
Dividend Growth | - | -73.33% | - | - | - |
Gross Margin | 100.00% | 64.18% | 66.63% | 63.11% | 64.50% |
Operating Margin | 0.15% | -1.34% | 6.71% | -2.63% | 14.34% |
Profit Margin | 1.48% | 2.80% | 8.53% | 4.87% | 16.43% |
Free Cash Flow Margin | - | -35.43% | -17.76% | -27.10% | -7.33% |
EBITDA | 45.26 | 34.08 | 84.67 | 16.28 | 70.73 |
EBITDA Margin | 5.85% | 4.55% | 12.49% | 3.66% | 20.38% |
D&A For EBITDA | 44.1 | 44.1 | 39.16 | 28.01 | 20.95 |
EBIT | 1.16 | -10.02 | 45.51 | -11.73 | 49.78 |
EBIT Margin | 0.15% | -1.34% | 6.71% | -2.63% | 14.34% |
Revenue as Reported | - | 749.55 | 678.08 | 445.26 | 347.05 |
Advertising Expenses | - | 5.66 | 1.64 | 2.4 | 1.02 |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.